Navigation Links
APIC Launches 'Targeting Zero' Initiative to Eradicate C. Difficile and Infections Deemed Preventable By CMS
Date:12/18/2007

Campaign will Arm Infection Prevention Professionals With Guidelines and Tools

WASHINGTON, Dec. 18 /PRNewswire-USNewswire/ -- The Association for Professionals in Infection Control and Epidemiology (APIC) today announced a series of new educational initiatives aimed at eliminating healthcare-associated infections (HAIs), which include Clostridium difficile-associated disease and the three infections that the Centers for Medicare & Medicaid Services (CMS) have classified as preventable occurrences: catheter-associated urinary tract infections (UTIs), central line catheter-associated blood stream infections, and mediastinitis (a deep infection following coronary artery bypass surgery). The APIC programs will provide a comprehensive package of education, research and guidance for infection prevention and control professionals.

"As the nation's largest infection prevention organization, we are leading an effort to eradicate these infections," said Kathy L. Warye, Chief Executive Officer of APIC. "The Targeting Zero Campaign is intended to accelerate both learning and the delivery of practical tools for infection prevention professionals. In keeping with our efforts to create a culture of zero tolerance for non-compliance with measures proven to prevent HAIs, this program will clearly demonstrate to healthcare administrators and clinicians how they can implement effective strategies and simpler systems for protecting patients from these deadly infections."

Launching in January 2008, APIC's comprehensive program to address C. difficile will include a prevalence study to gain a better understanding of the scope of the problem. C. difficile is a bacterium that causes diarrhea and more serious intestinal conditions such as colitis. Over the past two years, a new strain of C. difficile has caused hospital outbreaks in several states.

APIC also intends to develop a Guide to the Elimination of C. difficile, including strategies for controlling transmission; an educational Webinar series, and a conference in the fall of 2008, featuring results of the prevalence study, along with the latest science, epidemiology and best practices in the elimination of C. difficile transmission.

To help infection prevention and control professionals address new changes to the CMS regulations which eliminate or reduce payments for three hospital-acquired infections, APIC will offer comprehensive educational programs on each of the three infections, using nationally recognized clinicians to discuss elimination strategies. APIC will also develop an elimination guide with practical implementation strategies for each infection.

"We want to prepare infection prevention and control professionals to more effectively educate and influence front-line healthcare teams about process improvements that could ensure safe patient outcomes," said Denise Murphy, president of APIC and Vice President of Safety and Quality, and Chief Patient Safety and Quality Officer at Barnes-Jewish Hospital at Washington University Medical Center in St. Louis. "Leveraging the new CMS Guidelines, we hope to heighten awareness among clinical and administrative leadership about the value of infection prevention. Responding to this challenge requires a blend of research, education and practice guidance -- a combination of activities that APIC is uniquely positioned to undertake. Following our positive experience taking a very comprehensive approach to MRSA in 2007, we plan to launch an aggressive fight against these deadly infections on multiple fronts in 2008."

For more information, please visit http://www.apic.org

APIC's mission is to improve health and patient safety by reducing risks of infection and other adverse outcomes. The Association's more than 11,000 members have primary responsibility for infection prevention, control and hospital epidemiology in healthcare settings around the globe. APIC advances its mission through education, research, collaboration, practice guidance, public policy, and credentialing. Visit APIC online at http://www.apic.org


'/>"/>
SOURCE Association for Professionals in Infection Control andEpidemiology
Copyright©2007 PR Newswire.
All rights reserved

Related medicine technology :

1. Iomai Launches Phase 1/2 Safety Study of Dose-Sparing Patch for Use With Pandemic Influenza Vaccine
2. Keeping the Data Center Clean: ATEN Launches Industry-First KVM Switches with Antimicrobial Nanocoating to Protect Products from Bacteria Surviving on Surfaces
3. Cell Therapeutics, Inc. (CTI) Launches Phase III Study for Pixantrone in Relapsed Indolent Non-Hodgkins Lymphoma (NHL)
4. Tengion Launches Second Phase 2 Clinical Trial of Regenerated Human Organ
5. Strategic Diagnostics Launches Initial Oncology-Targeted Antibody Reagent Catalog
6. deCODE Launches Phase II Clinical Testing of DG051 for the Prevention of Heart Attack
7. Premier Micronutrient Launches Supplement for Hearing Health
8. deCODE Launches deCODE MI(TM) -- A Test for a Major Genetic Risk Factor for Early-onset Heart Attack
9. PDHI Launches ConXus Rewards, Announces Partnership With Hallmark Insights to Support Incentive-Driven Wellness Programs
10. Seal Shield Launches Worlds First Antibacterial, Dishwasher Safe Keyboard and Mouse for Infection Control
11. PositiveFriends.com Launches STD Social Networking Site Balancing Dating with Online Support Features
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/3/2016)... 3, 2016   BIOTRONIK , a leader ... Food and Drug Administration (FDA) approval of Iperia ... heart failure patients with access to diagnostic magnetic ... remote monitoring with daily automatic transmission and closed ... in response to physiological demands. ...
(Date:5/3/2016)... 3, 2016 According to market ... Development, Growth and Demand Forecast to 2022 - Industry ... (High Field, Very High Field, Low to Mid Field, ... Neck, Spine, Musculoskeletal, Vascular, Breast, Pelvic and Abdomen, Cardiac, ... imaging (MRI) market was valued at $5,351.7 million in ...
(Date:5/3/2016)... Norgine B.V. und ... entscheidenden Meilenstein durch diese Veröffentlichung zur  Hepatischen ... um Patientenresultate  bei Verdauungs- und Lebererkrankungen zu ... Verständnis der Hepatischen Enzephalopathie bei und hebt ... Enzephalopathie in der Öffentlichkeit zu schaffen und ...
Breaking Medicine Technology:
(Date:5/4/2016)... ... , ... Francesca Loparco, Co-Founder of Queen City Dream Cars, an exotic car ... procedure at Christenbury Eye Center. The entrepreneur struggled with her computer, riding horses ... day as her in-office consultation and eye exam. Francesca’s eyesight was restored to 20/20 ...
(Date:5/4/2016)... ... May 04, 2016 , ... Bayco Products ... tactical (6.7 inch) dual-light flashlights in models NSP-9842XL and NSR-9844XL . , ... starting at $59.95) uses 2 included CR-123 batteries to produce up to 650 ...
(Date:5/4/2016)... ... May 04, 2016 , ... Warren L. Smith M.D. , ... called UTIs, have plagued people since the beginning of recorded medical history, and ... infections every year. It's not just a matter of inconvenience; bladder infections cost us ...
(Date:5/4/2016)... ... 04, 2016 , ... DESCO Medical Service, also known as ... sterilization service and sales company located in Pennsylvania. The terms of the deal ... asset management services to the medical and academic research industries. The acquisition will ...
(Date:5/4/2016)... ... May 04, 2016 , ... Vasont Systems, a ... Integrator (VUI) extension supports the latest release of Adobe FrameMaker, Release 2015. The ... the process of creating, editing and storing XML. , The VUI ...
Breaking Medicine News(10 mins):